IL1B and colitis: In 2,4-dinitrobenzene sulfonic acid (DNBS)-induced colitis, treatment with verbascoside improved macroscopic damage, body weight, and inflammatory markers (TNF-α, IL-1β) while reducing oxidative stress and metalloproteinase activity (MMP-2 and MMP-9) in colon tissue [229,230].